Publikationen der ALS-Forschungsgruppe an der Charité
ALS-Phänotypen – Korrelation mit NfL, Progression und Prognose
Meyer T, Dreger M, Grehl T, Weyen U, Kettemann D, Weydt P,
ALSFRS-R-SE – eine selbsterklärende Version der ALS-Funktionsskala für Patienten und professionelle Nutzer
Maier A, Boentert M, Reilich P, Witzel S, Petri S, Großkreutz J,
Neurofilament light chain response during therapy with antisense oligonucleotide Tofersen in SOD1-related ALS – treatment experience in clinical practice
Meyer T, Schumann P, Weydt P, Petri S, Koc Y, Spittel S,
Neurofilament light chain (NfL) – Biomarker für die ALS-Progression
Meyer T, Salkic E, Grehl T, Weyen U, Kettemann D, Weydt P,
Der Einsatz von Patient-reported Outcome Measures (PROM) und die Perspektive digitaler Biomarker bei der Amyotrophen Lateralsklerose
Maier A, Münch C, Meyer T. Klinische Neurophysiologie 2023; 54(01): 28-34. doi:
Acceptance of Enhanced Robotic Assistance Systems in People With Amyotrophic Lateral Sclerosis-Associated Motor Impairment: Observational Online Study
Maier A, Eicher C, Kiselev J, Klebbe R, Greuèl M, Kettemann D,
Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité
A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS)
Janssens AI, Ruytings M, Al-Chalabi A,
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis
Vercruysse P, Sinniger J, El Oussini
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Freischmidt A, Wieland T, Richter B,
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study
Dorst J, Dupuis L, Petri S,
A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity
Joyce PI, Mcgoldrick P, Saccon RA,
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Küffner R, Zach N, Norel R,
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study
van Doormaal PT, Ticozzi N, Gellera
A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis
Lenglet T, Lacomblez L, Abitbol JL,
Live and let die: existential decision processes in a fatal disease
Lulé D, Nonnenmacher S, Sorg S,
In vivo waveguide elastography: effects of neurodegeneration in patients with amyotrophic lateral sclerosis
Romano A, Guo J, Prokscha T, Meyer
